Immunization against experimental murine salmonellosis with liposome-associated O-antigen
- PMID: 2581898
- PMCID: PMC261222
- DOI: 10.1128/iai.48.3.658-663.1985
Immunization against experimental murine salmonellosis with liposome-associated O-antigen
Abstract
Partially delipidated Salmonella typhimurium (O-1,4,5,12) lipopolysaccharide was incorporated into small multilamellar liposomes composed of either naturally occurring or synthetic phospholipids. Vaccination of mice with the liposome-lipopolysaccharide complexes induced a cellular response specific for O-1,4,5,12 determinants, as determined by the development of a delayed-type hypersensitivity reaction. The liposome-lipopolysaccharide vaccines were significantly more effective, compared with other nonviable vaccines tested, in protecting mice against a lethal intravenous challenge infection with virulent S. typhimurium. Protection afforded by the liposome-lipopolysaccharide vaccines was comparable to that conferred by a live S. typhimurium vaccine. Results suggest that liposome-induced modulation of the host immune response in favor of cell-mediated immunity may be more efficacious in preventing diseases in which cell-mediated immunity is of prime importance.
Similar articles
-
Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen.Vaccine. 1996 Mar;14(4):251-9. doi: 10.1016/0264-410x(95)00249-z. Vaccine. 1996. PMID: 8744548
-
An enterobacterial common antigen mutant of Salmonella enterica serovar Typhimurium as a vaccine candidate.Int J Med Microbiol. 2015 Sep;305(6):511-22. doi: 10.1016/j.ijmm.2015.05.004. Epub 2015 Jun 1. Int J Med Microbiol. 2015. PMID: 26070977
-
Protection of C3H/HeJ mice from lethal Salmonella typhimurium LT2 infection by immunization with lipopolysaccharide-lipid A-associated protein complexes.Infect Immun. 1986 Oct;54(1):1-8. doi: 10.1128/iai.54.1.1-8.1986. Infect Immun. 1986. PMID: 3531011 Free PMC article.
-
Ribonucleic acid in the immune response.Mol Cell Biochem. 1978 Aug 16;20(3):131-47. doi: 10.1007/BF00243760. Mol Cell Biochem. 1978. PMID: 81465 Review.
-
Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides.Clin Infect Dis. 1992 Aug;15(2):346-61. doi: 10.1093/clinids/15.2.346. Clin Infect Dis. 1992. PMID: 1381621 Review.
Cited by
-
Altered in vivo activity of liposome-incorporated lipopolysaccharide and lipid A.Infect Immun. 1989 Nov;57(11):3357-63. doi: 10.1128/iai.57.11.3357-3363.1989. Infect Immun. 1989. PMID: 2807528 Free PMC article.
-
Antibody responses in the serum and respiratory tract of mice following oral vaccination with liposomes coated with filamentous hemagglutinin and pertussis toxoid.Infect Immun. 1993 Feb;61(2):573-9. doi: 10.1128/iai.61.2.573-579.1993. Infect Immun. 1993. PMID: 8423087 Free PMC article.
-
Coincorporation of LpxL1 and PagL mutant lipopolysaccharides into liposomes with Neisseria meningitidis opacity protein: influence on endotoxic and adjuvant activity.Clin Vaccine Immunol. 2010 Apr;17(4):487-95. doi: 10.1128/CVI.00423-09. Epub 2010 Jan 27. Clin Vaccine Immunol. 2010. PMID: 20107001 Free PMC article.
-
Liposome potentiation of humoral immune response to lipopolysaccharide and O-polysaccharide antigens of Brucella abortus.Immunology. 1992 Sep;77(1):123-8. Immunology. 1992. PMID: 1398758 Free PMC article.
-
Adjuvanted outer membrane protein vaccine protects poultry against infection with Salmonella enteritidis.Vet Res Commun. 1999 Mar;23(2):81-90. doi: 10.1023/a:1006250301254. Vet Res Commun. 1999. PMID: 10359152
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical